Blue Sail Medical Co.,Ltd. (002382.SZ)
- Previous Close
5.16 - Open
5.59 - Bid 5.10 x --
- Ask 5.11 x --
- Day's Range
5.09 - 5.22 - 52 Week Range
4.26 - 7.94 - Volume
5,236,900 - Avg. Volume
9,651,489 - Market Cap (intraday)
5.146B - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.58 - Earnings Date --
- Forward Dividend & Yield 0.40 (7.75%)
- Ex-Dividend Date May 31, 2023
- 1y Target Est
--
Blue Sail Medical Co.,Ltd. engages in the health protection, medical device, and nursing businesses in China and internationally. It offers health protection gloves comprising disposable medical, latex, nitrile, PVC, and TPE/CPE gloves for applications in medical inspection and protection, industrial labor insurance, catering services, housework, and other areas. The company is also involved in the research, development, production, and sales of cardiac stents, coronary implantation and intervention, structural heart disease, and medical device products related to cardiac surgery. In addition, it provides first aid kits, medical first aid bags, family disaster prevention emergency kits and other first aid kits, epidemic prevention kits, reflective vests, masks, medical dressing products, etc. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is headquartered in Zibo, China.
www.bluesail.cn7,373
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Related News
Performance Overview: 002382.SZ
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002382.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002382.SZ
Valuation Measures
Market Cap
5.20B
Enterprise Value
7.19B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.08
Price/Book (mrq)
0.52
Enterprise Value/Revenue
1.52
Enterprise Value/EBITDA
-15.23
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.33%
Return on Assets (ttm)
-2.63%
Return on Equity (ttm)
-5.60%
Revenue (ttm)
4.73B
Net Income Avi to Common (ttm)
-583.24M
Diluted EPS (ttm)
-0.58
Balance Sheet and Cash Flow
Total Cash (mrq)
1.49B
Total Debt/Equity (mrq)
35.13%
Levered Free Cash Flow (ttm)
-962.26M